Basic Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Feb 7, 2015; 21(5): 1457-1467
Published online Feb 7, 2015. doi: 10.3748/wjg.v21.i5.1457
Table 3 Histologic features of colorectal cancers in patients with loss of CDX2 expression n (%)
ParametersCDX2-retained671 (94.1)Loss of CDX2 expression42 (5.9)P value
Differentiation< 0.0011
Differentiated656 (97.8)31 (73.8)
Undifferentiated15 (2.2)11 (26.2)
Luminal necrosis0.0531
Absent61 (9.1)8 (19.1)
Present610 (90.9)34 (80.9)
Tumor budding> 0.9991
Absent29 (4.3)1 (2.4)
Present642 (95.7)41 (97.6)
Tumor-infiltrating lymphocytes0.013
Low (< 8/HPF)513 (76.4)25 (59.5)
High (≥ 8/HPF)158 (23.6)17 (40.5)
Crohn’s-like lymphoid reaction< 0.0011
Absent552 (82.3)32 (76.2)
Present119 (17.7)10 (23.8)
Luminal serration< 0.0011
Absent641 (95.5)32 (7.2)
Present30 (4.5)10 (23.8)
Mucin production0.016
Absent595 (88.7)32 (76.2)
Present76 (11.3)10 (23.8)